Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis

Abstract

Using voriconazole first-line for treatment of IA resulted in significantly fewer deaths and similar treatment costs. Hospital-free survival was significantly greater for patients initially treated with voriconazole.